We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Merck KGaA (PK) | USOTC:MKKGY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.15 | -0.47% | 31.63 | 23.65 | 33.29 | 32.0699 | 31.46 | 31.72 | 25,595 | 21:57:01 |
From May 2019 to May 2024
By Cecilia Butini
Merck KGaA said Monday that it has appointed Belen Garijo as deputy chief executive and vice chairman of the executive board effective immediately.
Ms. Garijo joined Merck in 2011 as chief operating officer of the biopharma business and was named to the board in 2015, the German pharmaceuticals and life sciences company said. She is currently CEO of the healthcare business and heads the corporate functions human resources and environment, health, safety, security, quality.
The company also said Udit Batra, chief executive of the life sciences branch, is leaving the company to pursue other opportunities.
Christos Ross will be in charge of the life science business sector on an interim basis. Merck Chief Financial Officer Marcus Kuhnert will take over additional executive board responsibility for Information Technology, the company said.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
July 13, 2020 09:41 ET (13:41 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Merck KGaA (PK) Chart |
1 Month Merck KGaA (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
